RESUMO
Colorectal Cancer is a common type of cancer encountered in medical oncology practice. Many patients are presenting in advance stage of disease and the rest are requiring adjuvant therapy after surgery. The results of the current standard therapy so far are not encouraging. This review is addressing the issue related to the new chemotherapy agents that have been recently introduced to clinical practice. Those recently published studies utilizing these chemotherapeutic agents are highlighted in this review
Assuntos
Humanos , Protocolos de Quimioterapia Combinada Antineoplásica , Fluoruracila , Leucovorina , Pirimidinas , Desoxicitidina/análogos & derivados , Trimetrexato , Tiofenos , Camptotecina/análogos & derivados , Compostos Organoplatínicos , Tegafur , Antineoplásicos , Uracila , Resultado do TratamentoRESUMO
We report a 40 year old Bahraini female, a case of metastatic breast cancer who experienced paralytic ileus, an uncommon acute complication of Navelbine therapy when it was given in combination with Docetaxel. The diagnosis was made on clinical examination and confirmed by a plain X-ray of the abdomen, which showed multiple fluid levels. The management was conservative in view of the acute toxicity of Navelbine therapy being self-limiting